Full article view2018-07-17T08:45:50+00:00
Back to News & Insights »

Impact of market access factors in the adoption of biosimilar anti-TNFs across Europe

The recent entry of biosimilar anti-TNFs into the European markets has attracted considerable attention—much of it centered on competitive discounting. Yet proprietary research with key payers and clinicians from 9 European countries shows that customer decisions are largely not based on price. Discover the initiatives that can incentivize these influential decision-makers and when to most effectively leverage each in the decision-making chain.

Get the brief
[contact-form-7 id="" title=""]

    Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.